Kemin Industries Acquires Antimicrobial Firm to Increase Product Choices for US Biofuel Business.
Kemin Industries, a world ingredient producer that strives to sustainably remodel the standard of life day-after-day for 80 p.c of the world’s inhabitants with its services and products, has acquired Archangel Inc., an organization specializing in antimicrobials for fermentative biofuel manufacturing.
Based in 2015 by Allen Ziegler, Archangel Inc. has centered on growing superior bacterial management options tailor-made particularly to the fermentation of biofuels for the renewable power business. Leveraging over 30 years of expertise within the biofuels sector, Ziegler has led the event of progressive applied sciences and customer support choices to deal with the distinctive challenges of bacterial management in biofuel manufacturing processes. With this acquisition, he joins Kemin as a Principal Gross sales Supervisor for the Kemin Bio Options enterprise unit.
Jason Ackerman, Common Supervisor, Kemin Bio Options, mentioned:
This acquisition is a big milestone for Kemin as we proceed to broaden our presence within the biofuels sector.
“Archangel’s experience and progressive antibiotic-free applied sciences complement our current portfolio, permitting us to supply new and important choices to our clients.”
With the acquisition of Archangel Inc., Kemin enhances its portfolio of antimicrobial options with the NOVA™ EZL and NOVA™ EZP merchandise that help biofuel manufacturing. The acquisition additionally transfers 4 full patent purposes from Archangel to Kemin. The brand new NOVA™ merchandise won’t solely strengthen Kemin’s capacity to supply complete options for bacterial management in biofuel manufacturing processes, but additionally pave the best way for thrilling improvements within the area. Clients can sit up for enhanced product choices and devoted help as Kemin continues to push the boundaries of biofuel manufacturing within the U.S.
Ziegler, mentioned:
I’m excited to hitch forces with Kemin and contribute my experience to the group.
“Collectively, we’re well-positioned to drive developments in bacterial management options for the biofuels business, in the end benefiting our clients.”
Dr. Chris Nelson, President and CEO, Kemin Industries, mentioned:
This acquisition signifies a pivotal alternative for the growth of the Kemin Bio Options group.
“With Archangel’s portfolio of antimicrobials and technical experience within the biofuels business, its shared endeavors with Kemin will reinforce our dedication to delivering excellent worth to the biofuels sector and our clients.”
READ the newest information shaping the biofuels market at Biofuels Central
Kemin Industries Acquires Antimicrobial Firm to Increase Product Choices for US Biofuel Business. supply
